JP Patent

JP6026268B2 — ファブリー病に対する治療の選択を診断し、評価するためのアッセイ

Assigned to アミカス セラピューティックス インコーポレイテッド · Expires 2016-11-16 · 9y expired

What this patent protects

Patent listed against migalastat-hydrochloride.

Drugs covered by this patent

Patent Metadata

Patent number
JP6026268B2
Jurisdiction
JP
Classification
—
Expires
2016-11-16
Drug substance claim
No
Drug product claim
No
Assignee
アミカス セラピューティックス インコーポレイテッド
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.